Companies in the pharmaceutical sector have been facing fierce competition, cost pressure, technological innovations, an...
Eurofins DiscoverX Products LLC, a global industry leader in products for small and large molecule drug discovery a...
Merck has announced that its Life Science business sector has doubled its high-potent active pharmaceutical ingredients ...
WuXi Biologics, a global contract research, development and manufacturing organisation (CRDMO) service company, has succ...
South Korea-based Hanmi Fine Chemical, a subsidiary of Hanmi Pharmaceutical Group specializing in APIs (Active Pharmaceu...
Senator h.c. Udo J. Vetter, Chairman of the Advisory Board and member of the owner family (second from left) along with ...
South Korean firm LOTTE has agreed to purchase Bristol Myers Squibb’s manufacturing facility in East Syracuse, New...
GenScript ProBio, a global CDMO company from GenScript Biotech Corporation, has announced the opening of a legal entity ...
Taiwan-based contract development and manufacturing organization (CDMO) Bora Pharmaceuticals has recently announced the ...
Avantor, Inc. has announced that it will create a new manufacturing and distribution Hub in Singapore, by integrating it...
Japan-based Asahi Kasei Medical has concluded an agreement through a US subsidiary to wholly acquire Bionova S...
Thermo Fisher Scientific has opened its new single-use technology manufacturing site in Ogden, Utah in the US. The state...
GC corp., the holding (system) company for GC group in South Korea with major operating companies across healthcare se...
US-based VectorBuilder Inc. has announced the construction of a new R&D and manufacturing centre in Guangzhou, China...
CHA Medical & Bio Group officially began construction of its Cell Gene Biobank (CGB) facility in Pangyo, South Korea...
Exothera was founded in 2020 to help tackle two of the most critical challenges manufacturers face in bringing adva...
Japan-based FUJIFILM Corporation has announced that FUJIFILM Irvine Scientific, Inc., a world leader in the development ...
WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, announced the launch of Tetracycline-Enabl...
